John Graham, Group CEO of Zuellig Pharma, shares how big pharmaceutical companies are taking steps to mitigate the fallout from new U.S. tariffs.
.
Health
Big pharma already hedging risk to reduce reliance on China: Zuellig Pharma

John Graham, Group CEO of Zuellig Pharma, shares how big pharmaceutical companies are taking steps to mitigate the fallout from new U.S. tariffs.